More on VCEL
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $41.02 |
|
|||
| Open | $41.07 | ||||
| 52 Wk High | $6.69 | ||||
| 52 Wk Low | $1.69 | ||||
| Day High | $41.55 | ||||
| Day Low | $39.71 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 737,149 | ||||
- Vericel Corporation (VCEL) PT Lowered to $52 at Truist Securities
- Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.
- MediWound gets $3.3M more from U.S. government for NexoBrid program
- MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid®
- Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026
- Form 4 Vericel Corp For: Aug 12 Filed by: MCLAUGHLIN KEVIN F
- Form SCHEDULE 13G/A Vericel Corp Filed by: Soleus Capital Master Fund, L.P.
- Form 144 Vericel Corp Filed by: MCLAUGHLIN KEVIN F
- Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It
- Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It
Entities mentioned with VCEL
- Earnings | View Related Stories »
- FDA | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- Needham & Company | View Related Stories »
- Show More...
